Remicade and Demadex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remicade (infliximab) and Demadex (torsemide). Common drug interactions include cardiomegaly among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Remicade and Demadex. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Demadex?

Demadex has active ingredients of torsemide. It is often used in heart failure. eHealthMe is studying from 5,358 Demadex users. Check the latest studies of Demadex.



On Jul, 16, 2026

44 people who take Remicade and Demadex together, and have interactions are studied.

Remicade and Demadex drug interactions.

What are the common drug interactions of Remicade and Demadex, by gender? *:

female:

  1. Cardiomegaly (increased size of heart than normal)
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Constipation
  4. Cough
  5. Depression
  6. Dizziness
  7. Excoriation (to tear or wear off the skin of)
  8. Fluid overload (too much fluid in the blood)
  9. Haematocrit
  10. Haemorrhage (bleeding)

male:

  1. Anxiety
  2. Arthralgia (joint pain)
  3. Dyspnoea (difficult or laboured respiration)
  4. Fall
  5. Hallucination (an experience involving the perception of something not present)
  6. Hyperkeratosis (thickening of the outer layer of the skin)
  7. Hypoaesthesia (reduced sense of touch or sensation)
  8. Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
  9. Mitral valve incompetence (inefficient heart valve)
  10. Mycobacterium avium complex (a group of bacteria that are related to tuberculosis and can severely affect those infected by hiv)

What are the common drug interactions of Remicade and Demadex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Pain
  2. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)

50-59:

  1. Intestinal obstruction
  2. Lip dry
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Nausea (feeling of having an urge to vomit)
  5. Urinary tract infection
  6. Weakness
  7. Asthenia (weakness)
  8. Chest pain
  9. Chills (felling of cold)
  10. Diarrhoea

60+:

  1. Fall
  2. Arthralgia (joint pain)
  3. Cardiac pacemaker malfunction
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Coccidioidomycosis (serious disease of the lungs and other tissues, caused by the fungus coccidioides immitis)
  6. Dyspnoea (difficult or laboured respiration)
  7. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  8. Hypotension (abnormally low blood pressure)
  9. Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
  10. Onychomadesis (a periodic idiopathic shedding of the nails)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 21 people, 47.73%
  2. Pain: 4 people, 9.09%
  3. Urinary Tract Infection: 3 people, 6.82%
  4. Neuropathy Peripheral (surface nerve damage): 3 people, 6.82%
  5. Joint Pain: 3 people, 6.82%
  6. Insomnia (sleeplessness): 3 people, 6.82%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.82%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 6.82%
  9. Fibromyalgia (a long-term condition which causes pain all over the body): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and Demadex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Remicade and Demadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Demadex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remicade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Demadex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on infliximab and torsemide (the active ingredients of Remicade and Demadex, respectively), and Remicade and Demadex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: